Japonya\u2019daki bilim insanlar\u0131, insanlarda di\u015flerin yine b\u00fcy\u00fcmesini m\u00fcmk\u00fcn k\u0131labilecek deneysel bir ila\u00e7 geli\u015ftirdi. Klinik deneylerin ba\u015far\u0131l\u0131 olmas\u0131 halinde tedavinin 2030 y\u0131l\u0131na kadar geni\u015f kitlelere ula\u015fabilece\u011fi belirtiliyor.<\/p>\n
\u0130nsan bedeni 206 kemikten olu\u015fuyor ve bu kemikler k\u0131r\u0131ld\u0131\u011f\u0131nda kendilerini yine onarabiliyor. Lakin di\u015fler t\u0131pk\u0131 avantaja sahip de\u011fil. Bedenin en sert malzemesi olmalar\u0131na kar\u015f\u0131n, kendilerini onarma yahut tekrar b\u00fcy\u00fctme yetenekleri bulunmuyor. \u0130\u015fte bu noktada Japon ara\u015ft\u0131rmac\u0131lar\u0131n \u00fczerinde \u00e7al\u0131\u015ft\u0131\u011f\u0131 yeni ila\u00e7, di\u015fsizlik s\u0131k\u0131nt\u0131s\u0131na tahlil olabilir.<\/p>\n
HAYVAN DENEYLER\u0130NDEN \u0130NSAN DENEYLER\u0130NE GE\u00c7\u0130LD\u0130<\/b><\/p>\n
\u00c7al\u0131\u015fmalar\u0131n temelinde, USAG-1<\/strong> ismi verilen ve di\u015f b\u00fcy\u00fcmesini engelledi\u011fi g\u00f6sterilen \u00f6zel bir antikor yer al\u0131yor. Kyoto \u00dcniversitesi\u2019nden bilim insanlar\u0131 2021\u2019de bu antikor ile kemik morfojenetik proteinler (BMP) ortas\u0131ndaki etkile\u015fimi bozarak di\u015f b\u00fcy\u00fcmesini tetikleyen bir usul ke\u015ffetmi\u015fti. Gelinciklerde yap\u0131lan deneylerde ba\u015far\u0131l\u0131 sonu\u00e7lar al\u0131nmas\u0131, ara\u015ft\u0131rmac\u0131lar\u0131 klinik denemelere y\u00f6neltti.<\/p>\n 30 ERKEK \u00dcZER\u0130NDE DENEN\u0130YOR<\/b><\/p>\n Eyl\u00fcl 2024\u2019te ba\u015flayan insan deneyleri kapsam\u0131nda, 30 ila 64 ya\u015flar\u0131 ortas\u0131nda en az bir di\u015fi eksik olan 30 erkek \u00fczerinde \u00e7al\u0131\u015fmalar y\u00fcr\u00fct\u00fcl\u00fcyor. \u0130la\u00e7 damar yoluyla uygulan\u0131yor ve deney s\u00fcreci 11 ay s\u00fcrecek. Evvelki hayvan deneylerinde rastgele bir yan tesire rastlanmam\u0131\u015f olmas\u0131 umutlar\u0131 art\u0131r\u0131yor.<\/p>\n E\u011fer sonu\u00e7lar olumlu \u00e7\u0131karsa, Kitano Hastanesi bu tedaviyi 2 ila 7 ya\u015f ortas\u0131nda, do\u011fu\u015ftan d\u00f6rt di\u015fi eksik olan \u00e7ocuklara da uygulamay\u0131 planl\u0131yor. Kesin gaye ise 2030 y\u0131l\u0131na kadar di\u015f tekrar b\u00fcy\u00fctme ilac\u0131n\u0131n yayg\u0131n ve inan\u00e7l\u0131 formda kullan\u0131labilir hale gelmesi.<\/p>\n UMUT VERD\u0130<\/b><\/p>\n Ara\u015ft\u0131rman\u0131n \u00f6nc\u00fclerinden Katsu Takahashi, \u201cUSAG-1\u2019in bask\u0131lanmas\u0131n\u0131n di\u015f b\u00fcy\u00fcmesine katk\u0131 sa\u011flad\u0131\u011f\u0131n\u0131 biliyorduk. Art\u0131k bunun be\u015ferler i\u00e7in k\u00e2fi olup olmayaca\u011f\u0131n\u0131 g\u00f6rece\u011fiz\u201d diyerek geli\u015fmenin de\u011ferini vurgulad\u0131. Takahashi, tedavinin s\u0131rf do\u011fu\u015ftan di\u015f eksikli\u011fi ya\u015fayanlar i\u00e7in de\u011fil, ileride di\u015fini kaybetmi\u015f herkes i\u00e7in uygulanabilir olmas\u0131n\u0131 umuyor.<\/p>\n","protected":false},"excerpt":{"rendered":" Japonya\u2019da bilim insanlar\u0131, milyonlarca insan\u0131n hayat\u0131n\u0131 de\u011fi\u015ftirebilecek bir \u00e7al\u0131\u015fmaya imza att\u0131. Ara\u015ft\u0131rmac\u0131lar, kaybolan di\u015flerin tekrar b\u00fcy\u00fcmesini sa\u011flayabilecek deneysel bir ila\u00e7 \u00fczerinde klinik denemelere ba\u015flad\u0131.<\/p>\n","protected":false},"author":1,"featured_media":79731,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[29],"tags":[103,1921,711],"class_list":["post-79730","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-dis","tag-ila","tag-insan"],"_links":{"self":[{"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/posts\/79730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/comments?post=79730"}],"version-history":[{"count":1,"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/posts\/79730\/revisions"}],"predecessor-version":[{"id":79732,"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/posts\/79730\/revisions\/79732"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/media\/79731"}],"wp:attachment":[{"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/media?parent=79730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/categories?post=79730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ikimisli.tr\/index.php\/wp-json\/wp\/v2\/tags?post=79730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}